Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 67184-0549

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 67184-0549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Daptomycin 01)

FDA Label Image

Principal Display Panel (500 mg Vial)

Principal Display Panel (500 mg Vial)
This appears to be a label or packaging information for a medication called Daptomycin. It is provided in a vial which needs to be refrigerated. The medication is for intravenous infusion and should be used as per instructions from a healthcare professional. The label also mentions reconstitution with Sodium Chloride injection. The manufacturer name is Qi Pharmaceuticals from Hainsan, China.*
FDA Label Image

Principal Display Panel (500 mg Carton)

Principal Display Panel (500 mg Carton)
This is a description of a medication called Daptomycin for injection, which is intended for intravenous infusion. The medication comes in a single-dose vial with a concentration of 1500g per vial. The package does not contain any preservatives and must be refrigerated at 5 to 45 degrees Fahrenheit. The package insert provides information on reconstitution and dosage. The medication should be used with 0.5% Sodium Chloride Injection, and any unused portion should be discarded. The product is manufactured by the Giu Pharmaceutical Company located in Hakou, China.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.